IC3: Pharmacology Flashcards
What are the 4 phases of hemostasis?
Vasoconstriction
Primary hemostasis
Secondary hemostasis
Clot stabilisation
What drugs should be used for the latter 3 stages of hemostasis?
Primary hemostasis - antiplatelets
Secondary hemostasis - anticoagulants
Clot stabilisation - fibrinolytics
What are the 3 classes of antiplatelets and their respective drugs?
Adenosine uptake and PDE3i - dipyridamole
COX-1 inhibitor - aspirin
ADP P2Y12 inhibitors - clopidogrel, ticagrelor
Explain the MOA of dipyridamole
Dipyridamole inhibits adenosine reuptake, increasing plasma adenosine activation of A2 receptors on platelets, which then increases cAMP levels which inhibit platelet activation and aggregation
It also inhibits PDE3, hence reducing cAMP degradation in platelets
Explain the main side effect of dipyridamole and why this occurs
Hypotension (dose-limiting SE) as dipyridamole acts as a vasodilator and inhibits adenosine reuptake and PDEs in vascular smooth muscle as well
Explain the MOA of aspirin
Aspirin is an irreversible cyclooxygenase (COX) inhibitor, inhibiting COX-1 more than COX-2 at lower doses
COX-1 (platelets) normally produces TXA2 which promotes platelet aggregation (effects for 7-10d)
COX-2 (endothelial cells) expresses PGI2 which inhibits platelet aggregation (effects for 3-4h)
What is the main side effect for aspirin
Upper GI events (gastric ulcers, bleeding), as aspirin inhibits COX-1 production of protective PGs in the stomach
Why is ADP P2Y12 important in platelet aggregation?
Platelets release ADP from their granules which act on the P2Y12 receptor, which plays an important role in activating GP IIb/IIIa receptors
Explain how clopidogrel works
Clopidogrel is a prodrug whereby the active metabolite (metabolised by CYP2C19) irreversibly binds to the ADP binding site of P2Y12
Explain how ticagrelor works
Ticagrelor and its metabolites binds reversibly at an allosteric site of P2Y12
What are the main contraindications to clopidogrel and ticagrelor? (2 + 1 for ticagrelor)
Hypersensitivity
Pathological bleeding (eg. PUD)
Severe hepatic impairment for ticagrelor
DDIs for clopidogrel (6)
warfarin
NSAIDs
salicylates
macrolides
PPI
CYP2C19 inhibitors
DDIs for ticagrelor (6)
anticoagulants
fibrinolytics
long-term NSAIDs
aspirin (>100mg/day)
CYP3A4 inducers
CYP3A34 strong inhibitors
What are the 3 classes of anticoagulants?
VKA - warfarin
DOACs - dabigatran (DTI, IIa), rivaroxaban (Xa)
Parenteral ACs - heparin, LMWH (enoxaparin)
How is vitamin K used in the coagulation pathway?
Active vitamin K is oxidised to inactive vitamin K to carboxylate glutamic acid residues on factors II, VII, IX and X
What is warfarin’s MOA
Warfarin inhibits vitamin K reductase that normally reactivates oxidised vitamin K
What are the 2 genetic polymorphisms implicated in warfarin use?
CYP2C19
VKORC1
What are the 3 main side effects of warfarin?
Bleeding
Hepatitis
Cutaneous necrosis
DDIs with warfarin? (10)
Paracetanol
allopurinol
NSAIDs
salicylates
PPIs
metronidazole
barbituates
corticosteroids
spironolactone
thiazides
CI for warfarin (5)
hypersensitivity
active bleeding
HTN
renal or hepatic disease
pregnancy
What is dabigatran etexilate’s MOA
Dabigatran etexilate is a prodrug that is rapidly converted to dabigatran, and dabigatran and its acyl glucuronide metabolites are competitive reversible non-peptide antagonists of thrombin (factor IIa)
What are the adverse effects of dabigatran (2)
bleeding
GI symptoms (dyspepsia, abd discomfort)
What is the reversal agent for dabigatran and what is its MOA?
Idarucizumab, binds dabigatran and its acyl glucuronide metabolites with higher affinity than dabigatran binds to thrombin
What is the MOA of rivaroxaban?
Rivaroxaban is a competitive reversible antagonist of activated factor Xa